Transcriptomics

Dataset Information

0

The transcription factor c-Jun inhibits RBM39 to reprogram pre-mRNA splicing during genotoxic stress

ABSTRACT: Gene expression and pre-mRNA splicing events were examined in human breast adenocarcinoma (MCF7) cells treated or not with cisplatin and various siRNAs.

ORGANISM(S): Homo sapiens

PROVIDER: GSE195842 | GEO | 2022/11/05

REPOSITORIES: GEO

Json Xml

Similar Datasets

Unknown Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells.
| S-EPMC8277813 | biostudies-literature
Transcriptomics Gene expression and alternative splicing analysis of breast carcinoma cells treated by cisplatin.
2016-04-22 | E-MTAB-2663 | biostudies-arrayexpress
Unknown UHM-ULM interactions in the RBM39-U2AF65 splicing-factor complex.
| S-EPMC4822562 | biostudies-literature
Unknown RBM39 Alters Phosphorylation of c-Jun and Binds to Viral RNA to Promote PRRSV Proliferation.
| S-EPMC8165236 | biostudies-literature
Unknown Negative autoregulation of BMP dependent transcription by SIN3B splicing reveals a role for RBM39.
| S-EPMC4914931 | biostudies-literature
Unknown Selective aggregation of the splicing factor Hsh155 suppresses splicing upon genotoxic stress.
| S-EPMC5716266 | biostudies-literature
Unknown Genotoxic stress inhibits Ewing sarcoma cell growth by modulating alternative pre-mRNA processing of the RNA helicase DHX9.
| S-EPMC4741636 | biostudies-literature
Transcriptomics Next Generation Sequencing Facilitates Quantitative Analysis of RBM39 knockdown Transcriptomes in T47D cells
2021-04-13 | GSE144376 | GEO
Transcriptomics Real-time Monitoring of Cisplatin Toxicity on Cancer Cells
2011-04-04 | E-GEOD-28274 | biostudies-arrayexpress
Genomics Evaluating microRNA profiles reveals discriminative responses following genotoxic or non-genotoxic carcinogen exposure in primary mouse hepatocytes [Exiqon]
2015-05-18 | GSE57082 | GEO